Zealand Pharma A/S (LON:0NZU)
323.31
-19.94 (-5.81%)
At close: Aug 1, 2025
Zealand Pharma Revenue
Zealand Pharma had revenue of 8.09M DKK in the quarter ending March 31, 2025, a decrease of -46.37%. This brings the company's revenue in the last twelve months to 55.69M, down -83.82% year-over-year. In the year 2024, Zealand Pharma had annual revenue of 62.69M, down -81.71%.
Revenue (ttm)
55.69M DKK
Revenue Growth
-83.82%
P/S Ratio
434.39
Revenue / Employee
166.25K DKK
Employees
335
Market Cap
2.71B GBP
Revenue Chart
* This company reports financials in DKK.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 62.69M | -280.10M | -81.71% |
Dec 31, 2023 | 342.79M | 238.80M | 229.65% |
Dec 31, 2022 | 103.99M | -4.56M | -4.20% |
Dec 31, 2021 | 108.55M | -83.46M | -43.47% |
Dec 31, 2020 | 192.00M | 150.67M | 364.52% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 41.24B |
HSBC Holdings | 41.03B |
Shell | 217.54B |
Unilever | 50.25B |
British American Tobacco p.l.c. | 25.87B |
Rolls-Royce Holdings | 18.91B |
Rio Tinto Group | 39.22B |
RELX PLC | 9.53B |